Skip to content
Disclosery

ACORN CAPITAL ADVISORS, LLC

Follow

13F filer, CIK 2054410, NEW YORK, NY

ACORN CAPITAL ADVISORS, LLC reported $351,837,734 across 22 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-15. Its ten largest share positions make up 88.87% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001636587-26-000029

Period
2026-03-31
Reported value
$352M
Holdings
22
Top 10 weight
88.87%
New
2
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
JBIOnew+786,760$11.1M
CADLadded+917,431$4.51M
URGNadded+225,000$4.05M
KPTInew+287,826$1.6M
LONAadded+132,800$1.37M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
QTTBreduced-178,373-$1.15M
ACRVexited-405,237-$977K
JSPRreduced-375,000-$330K
CRDFreduced-200,000-$324K
X4 PHARMACEUTICALS INCreduced-39,310-$162K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001636587-26-000029, largest first. % of portfolio is the value over $351,837,734, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 1,971,264 shares; 2025Q1: 1,971,264 shares; 2025Q2: 1,971,264 shares; 2025Q3: 1,971,264 shares; 2025Q4: 1,746,264 shares; 2026Q1: 1,746,264 shares 1,746,264$92.1M26.17%0Timeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 1,131,501 shares; 2025Q1: 1,131,501 shares; 2025Q2: 1,131,501 shares; 2025Q3: 1,131,501 shares; 2025Q4: 1,131,501 shares; 2026Q1: 1,130,501 shares 1,130,501$76.6M21.77%-1,000Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 1,516,303 shares; 2025Q1: 1,516,303 shares; 2025Q2: 1,259,749 shares; 2025Q3: 1,259,749 shares; 2025Q4: 1,448,420 shares; 2026Q1: 1,673,420 shares 1,673,420$30.1M8.55%+225,000Timeline
PBYIPUMA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 3,940,052 shares; 2025Q1: 3,940,052 shares; 2025Q2: 4,131,299 shares; 2025Q3: 4,131,299 shares; 2025Q4: 4,131,299 shares; 2026Q1: 4,131,299 shares 4,131,299$26.4M7.5%0Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 2,001,048 shares; 2025Q1: 2,144,844 shares; 2025Q2: 2,144,844 shares; 2025Q3: 2,144,844 shares; 2025Q4: 2,144,844 shares; 2026Q1: 2,144,844 shares 2,144,844$25.6M7.27%0Timeline
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 1,939,644 shares; 2025Q1: 2,152,252 shares; 2025Q2: 2,580,517 shares; 2025Q3: 2,580,517 shares; 2025Q4: 2,580,517 shares; 2026Q1: 3,497,948 shares 3,497,948$17.2M4.89%+917,431Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 643,381 shares; 2025Q1: 643,382 shares; 2025Q2: 643,382 shares; 2025Q3: 643,382 shares; 2025Q4: 643,382 shares; 2026Q1: 643,382 shares 643,382$12.8M3.64%0Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 1,439,674 shares; 2025Q1: 1,439,674 shares; 2025Q2: 2,839,674 shares; 2025Q3: 2,839,674 shares; 2025Q4: 2,839,674 shares; 2026Q1: 2,839,674 shares 2,839,674$11.8M3.34%0Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 786,760 shares 786,760$11.1M3.14%newTimeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 1,279,800 shares; 2025Q1: 1,279,800 shares; 2025Q2: 1,752,115 shares; 2025Q3: 1,752,115 shares; 2025Q4: 1,752,115 shares; 2026Q1: 1,752,115 shares 1,752,115$9.13M2.59%0Timeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 779,498 shares; 2025Q1: 779,498 shares; 2025Q2: 779,498 shares; 2025Q3: 779,498 shares; 2025Q4: 1,469,153 shares; 2026Q1: 1,469,153 shares 1,469,153$7.79M2.21%0Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 734,393 shares; 2025Q1: 734,394 shares; 2025Q2: 734,394 shares; 2025Q3: 734,394 shares; 2025Q4: 1,573,023 shares; 2026Q1: 1,540,266 shares 1,540,266$7.39M2.1%-32,757Timeline
LONALEONABIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 501,739 shares; 2026Q1: 634,539 shares 634,539$6.52M1.85%+132,800Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 590,508 shares; 2025Q2: 595,744 shares; 2025Q3: 595,744 shares; 2025Q4: 595,744 shares; 2026Q1: 595,744 shares 595,744$3.99M1.13%0Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 1,147,052 shares; 2025Q1: 1,139,363 shares; 2025Q2: 1,139,363 shares; 2025Q3: 1,139,363 shares; 2025Q4: 1,139,363 shares; 2026Q1: 1,139,363 shares 1,139,363$3.93M1.12%0Timeline
CRDFCARDIFF ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 1,442,308 shares; 2025Q1: 1,442,308 shares; 2025Q2: 1,408,767 shares; 2025Q3: 1,962,084 shares; 2025Q4: 1,962,084 shares; 2026Q1: 1,762,084 shares 1,762,084$2.85M0.81%-200,000Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 803,425 shares; 2025Q1: 803,425 shares; 2025Q2: 803,425 shares; 2025Q3: 803,425 shares; 2025Q4: 493,425 shares; 2026Q1: 315,052 shares 315,052$2.02M0.57%-178,373Timeline
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 287,826 shares 287,826$1.6M0.46%newTimeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,382,640 shares; 2025Q4: 1,786,492 shares; 2026Q1: 1,411,492 shares 1,411,492$1.24M0.35%-375,000Timeline
X4 PHARMACEUTICALS INCX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 7,310,650 shares; 2025Q1: 7,310,650 shares; 2025Q2: 153,730 shares; 2025Q3: 273,349 shares; 2025Q4: 273,349 shares; 2026Q1: 234,039 shares 234,039$967K0.27%-39,310
BCABBIOATLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 4,032,046 shares; 2025Q1: 4,032,046 shares; 2025Q2: 4,835,111 shares; 2025Q3: 4,835,111 shares; 2025Q4: 4,835,111 shares; 2026Q1: 5,406,345 shares 5,406,345$865K0.25%+571,234Timeline
VYNEVYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 456,970 shares; 2025Q1: 785,938 shares; 2025Q2: 736,572 shares; 2025Q3: 586,572 shares; 2025Q4: 1,425 shares; 2026Q1: 1,425 shares 1,425$855<0.01%0Timeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ACRVACRIVON THERAPEUTICS INC405,237$977Kshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001636587-26-000029 base2026-05-15acceptance time not in the bulk data set